via Health Care https://ift.tt/3zkiYG8 The FDA panel will vote Friday afternoon about whether to recommend the Pfizer-BioNTech booster for people 16 and older at least six months after their initial vaccination.
Tensions rise as FDA advisory panel weighs evidence on Pfizer booster
0 Comments